These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 6210068)

  • 1. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A; Nakahara H; Hara Y
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
    Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of arotinolol in anesthetized dogs and its affinities for adrenoceptors in vitro.
    Hashimoto H; Asano M; Hayashi T; Oguro K; Takiguchi Y; Nakashima M
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):23-34. PubMed ID: 6202253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new beta 2-adrenoceptor agonist with alpha 1-adrenoceptor blocking properties.
    Olsson OA; Ahlquist B; Gustafsson B
    Acta Pharmacol Toxicol (Copenh); 1981 Apr; 48(4):340-8. PubMed ID: 6121453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
    Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
    Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of 4-(2-hydroxy-3-[(1-methyl-3-phenylpropyl)-amino]propoxy)benzeneacetamide (KF-4317).
    Kubo K; Nakamura J; Karasawa A; Shuto K; Nakamizo N
    Arzneimittelforschung; 1983; 33(7):926-31. PubMed ID: 6138045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the beta 1-adrenoceptor blocking agent celiprolol have alpha 2-adrenoceptor blocking properties?
    Pittner H
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):199-210. PubMed ID: 2883946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).
    Honda K; Takenaka T; Miyata-Osawa A; Terai M
    J Pharmacol Exp Ther; 1986 Mar; 236(3):776-83. PubMed ID: 2869143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].
    Hara Y; Nakahara H; Miyagishi A; Nakatani H
    Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):103-16. PubMed ID: 6198264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the blood pressure of beta-adrenoceptor blocking drugs, particularly in relation to the mechanism of the pressor action induced by beta-adrenoceptor blocking drugs in rats (author's transl)].
    Maekawa H
    Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):251-61. PubMed ID: 6124489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ; Hodgson WC; Sutherland SK
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nipradilol (K-351) on alpha-adrenoceptor mediated responses in various isolated tissues.
    Ohira A; Wada Y; Fujii M; Nakamura M; Kasuya Y; Hamada Y; Shigenobu K
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):61-71. PubMed ID: 2869737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the hypotensive effect of a new beta-adrenergic blocking drug, arotinolol (S-596) in anesthetized rabbits.
    Nakahara H; Nakazawa M; Tsukada T; Imai S
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):253-63. PubMed ID: 2415080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of arotinolol, an alpha- and beta-adrenoceptor antagonist, on renin release from rat kidney cortical slices.
    Morimoto S; Miyawaki N; Sasaki Y; Matsumura Y
    Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):505-10. PubMed ID: 2428551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
    Farmer JB; Kennedy I; Levy GP; Marshall RJ
    Br J Pharmacol; 1972 Aug; 45(4):660-75. PubMed ID: 4404413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure lowering action and alpha-adrenolytic effect of adimolol in rats.
    Palluk R; Hoefke W
    Arch Int Pharmacodyn Ther; 1989; 301():215-27. PubMed ID: 2576194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extremely long-acting antihypertensive effects of KF-4317, a alpha- and beta 1-adrenoceptor blocker.
    Kubo K; Ikeda J; Nakamura J; Nakamizo N
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):140-60. PubMed ID: 2865934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.